伴有副蛋白的综合征经化疗成功治疗。
Paraprotein associated syndrome treated successfully with chemotherapy.
机构信息
The School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, UK.
出版信息
BMJ Case Rep. 2020 Sep 9;13(9):e232866. doi: 10.1136/bcr-2019-232866.
Abstract
We report a 50-year-old Caucasian woman who presented with recurrent erythema nodosum, leg swelling, malaise, weight loss and abdominal pain associated with an IgM lambda paraprotein. She was treated with six courses of an anti-CD20 monoclonal antibody and bendamustine chemotherapy over 6 months with a good clinical response.
摘要
我们报告了一例 50 岁的高加索女性，她表现为复发性结节性红斑、腿部肿胀、不适、体重减轻和腹痛，并伴有 IgM lambda 副蛋白。她在 6 个月内接受了 6 个疗程的抗 CD20 单克隆抗体和苯达莫司汀化疗，临床反应良好。
相似文献
1
Paraprotein associated syndrome treated successfully with chemotherapy.
BMJ Case Rep. 2020 Sep 9;13(9):e232866. doi: 10.1136/bcr-2019-232866.
2
Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature.
Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):e101-8. doi: 10.1016/j.clml.2016.04.004. Epub 2016 May 5.
3
Delayed development of the IgM paraprotein in Schnitzler's syndrome.
Scand J Rheumatol. 2015;44(6):521-2. doi: 10.3109/03009742.2015.1071421. Epub 2015 Sep 23.
4
Bilateral primary adrenal lymphoma successfully treated with non-CHOP chemotherapy regimen.
BMJ Case Rep. 2018 Aug 14;2018:bcr-2017-223078. doi: 10.1136/bcr-2017-223078.
5
Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine.
Blood. 2018 Aug 16;132(7):761-764. doi: 10.1182/blood-2018-04-846493. Epub 2018 Jun 20.
6
Marginal zone lymphoma-associated antiphospholipid antibodies successfully treated with bendamustine rituximab.
BMJ Case Rep. 2019 Mar 14;12(3):e224636. doi: 10.1136/bcr-2018-224636.
7
Bendamustine and Rituximab: Complete Response in a 62-Year-Old Female with an Aggressive Lymphoma and an Ejection Fraction of 20.
Chemotherapy. 2017;62(2):140-146. doi: 10.1159/000452756. Epub 2016 Dec 14.
8
IgM paraprotein-associated peripheral neuropathy: small CD20-positive B-cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness.
Br J Haematol. 2020 Feb;188(4):511-515. doi: 10.1111/bjh.16210. Epub 2019 Oct 6.
9
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study.
Ann Hematol. 2016 Jun;95(7):1107-14. doi: 10.1007/s00277-016-2668-0. Epub 2016 Apr 22.
10
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial.
Lancet Oncol. 2016 Aug;17(8):1081-1093. doi: 10.1016/S1470-2045(16)30097-3. Epub 2016 Jun 23.
本文引用的文献
1
A Rare but Fascinating Disorder: Case Collection of Patients with Schnitzler Syndrome.
Case Rep Rheumatol. 2018 Mar 8;2018:7041576. doi: 10.1155/2018/7041576. eCollection 2018.
2
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases.
Blood Adv. 2016 Nov 22;1(1):31-35. doi: 10.1182/bloodadvances.2016001412. eCollection 2016 Nov 29.
3
The Schnitzler syndrome: chronic urticaria in disguise: a single-centre report of 11 cases and a critical reappraisal of the literature.
Clin Exp Rheumatol. 2017 Jan-Feb;35(1):69-73. Epub 2016 Aug 31.
4
The Diagnosis and Treatment of Systemic Lupus Erythematosus.
Dtsch Arztebl Int. 2015 Jun 19;112(25):423-32. doi: 10.3238/arztebl.2015.0423.
5
Schnitzler's syndrome: lessons from 281 cases.
Clin Transl Allergy. 2014 Dec 5;4:41. doi: 10.1186/2045-7022-4-41. eCollection 2014.
6
Waldenstrom macroglobulinemia: prognosis and management.
Blood Cancer J. 2015 Mar 27;5(3):e394. doi: 10.1038/bcj.2015.28.
7
An update on autoinflammatory diseases.
Curr Med Chem. 2014;21(3):261-9. doi: 10.2174/09298673113206660303.
8
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.
Mayo Clin Proc. 2009 Aug;84(8):685-93. doi: 10.4065/84.8.685.
9
Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients.
Am J Clin Pathol. 2005 Feb;123(2):200-5.
10
TNFRSF1A mutations and autoinflammatory syndromes.
Curr Opin Immunol. 2000 Aug;12(4):479-86. doi: 10.1016/s0952-7915(00)00124-2.
Zotero 插件